Stroke in dialysis and chronic kidney disease

Blood Purification

Volumn 36, Issue 3-4, 2014, Pages 179-183

  Power, Albert ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic kidney disease; Dialysis; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DABIGATRAN; RIVAROXABAN; WARFARIN;

AGING; ARTICLE; ATHEROSCLEROSIS; BLEEDING; BLOOD VESSEL CALCIFICATION; BRAIN HEMORRHAGE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIALYSIS; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; INFLAMMATION; MALNUTRITION; PRIORITY JOURNAL; SURVIVAL RATE; UREMIA; AGE; COMORBIDITY; CONFERENCE PAPER; END STAGE RENAL DISEASE; HEMODIALYSIS; KIDNEY FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RISK BENEFIT ANALYSIS; RISK FACTOR; SURVIVAL; THERAPY EFFECT;

HUMANS; PATIENT OUTCOME ASSESSMENT; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK; STROKE;

EID: 84897556568     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000356086     Document Type: Article

References (30)

1. Norrving B, Kissela B: The global burden of stroke and need for a continuum of care. Neurology 2013; 80(3 suppl 2):S5-S12.
2. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112-123.
3. Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, et al: Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009; 119: 1363-1369.
4. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B: Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010; 341:c4249.
5. Ninomiya T, Perkovic V, Verdon C, Barzi F, Cass A, Gallagher M, et al: Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis 2009; 53: 417-425.
6. Power A, Chan K, Haydar A, Hamady M, Cairns T, Taube D, et al: Intracranial arterial calcification is highly prevalent in hemodialysis patients but does not associate with acute ischemic stroke. Hemodial Int 2011; 15: 256-263.
7. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011; 365: 1099-1107.
8. Power A, Chan K, Singh SK, Taube D, Duncan N: Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. Am J Kidney Dis 2012; 59: 249-257.
9. Power A, Davenport A, Brown EA, Duncan N, Fan S: Stroke incidence and risk factors in peritoneal dialysis (abstract). J Am Soc Nephrol 2012; 23: 227A.
10. Murray AM, Seliger S, Lakshminarayan K, Herzog CA, Solid CA: Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol 2013; 24: 1166-1173.
11. Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, et al: Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005; 45: 1058-1066.
12. Wetmore JB, Ellerbeck EF, Mahnken JD, Phadnis M, Rigler SK, Mukhopadhyay P, et al: Atrial fibrillation and risk of stroke in dialysis patients. Ann Epidemiol 2013; 23: 112-118.
13. Ovbiagele B, Sanossian N, Liebeskind DS, Kim D, Ali LK, Pineda S, et al: Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease. Cerebrovasc Dis 2009; 28: 582-588.
14. Lee JG, Lee KB, Jang IM, Roh H, Ahn MY, Woo HY, et al: Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke. Cerebrovasc Dis 2013; 35: 53-59.
15. Molshatzki N, Orion D, Tsabari R, Schwammenthal Y, Merzeliak O, Toashi M, et al: Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome. Cerebrovasc Dis 2011; 31: 271-277.
16. Agrawal V, Rai B, Fellows J, McCullough PA: In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke. Nephrol Dial Transplant 2010; 25: 1150-1157.
17. Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, et al: Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis 2011; 31: 123-129.
18. Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, et al: Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Cerebrovasc Dis 2013; 35: 45-52.
19. Tariq N, Adil MM, Saeed F, Chaudhry SA, Qureshi AI: Outcomes of thrombolytic treatment for acute ischemic stroke in dialysis-dependent patients in the United States. J Stroke Cerebrovasc Dis 2013, E-pub ahead of print.
20. Ovbiagele B: Chronic kidney disease and risk of death during hospitalization for stroke. J Neurol Sci 2011; 301: 46-50.
21. Ninomiya T, Perkovic V, Gallagher M, Jardine M, Cass A, Arima H, et al: Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: Progress trial. Kidney Int 2008; 73: 963-970.
22. Weiner DE, Tighiouart H, Levey AS, Elsayed E, Griffith JL, Salem DN, et al: Lowest systolic blood pressure is associated with stroke in stages 3-4 chronic kidney disease. J Am Soc Nephrol 2007; 18: 960-966.
23. Jardine MJ, Ninomiya T, Perkovic V, Cass A, Turnbull F, Gallagher MP, et al: Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. J Am Coll Cardiol 2010; 56: 956-965.
24. Olesen JB, Lip GY, Kamper AL, Hommel K, Kober L, Lane DA, et al: Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012; 367: 625-635.
25. Sood MM, Larkina M, Thumma JR, Tentori F, Gillespie BW, Fukuhara S, et al: Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS. Kidney Int 2013; 84: 600-608.
26. Chan KE, Lazarus JM, Thadhani R, Hakim RM: Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009; 20: 2223-2233.
27. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192.
28. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248.
29. Power A, Edwards C, Sawyer J, Tandaric D, Dahdaleh D, Taube D, et al: Screening for transient ischemic attacks in hemodialysis patients. J Nephrol 2013; 26: 919-924.
30. Mathew A, Eliasziw M, Devereaux PJ, Merino JG, Barnett HJ, Garg AX, et al: Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis. J Am Soc Nephrol 2010; 21: 145-152.